Immunome's Seed VC Round

Immunome raised a round of funding on May 10, 2010. Investors include BioAdvance.

Immunome is a start-up biopharmaceutical company with a patented native, human antibody platform which enables the company to harness the natural curative power of the human immune system. The Immunom…

Articles about Immunome's Seed VC Round: